Targeting Csnk1a1 in leukemia.
Dana-Farber Cancer Institute and Boston Children's Hospital.
Kimberly
K
Stegmaier
D000818:Animals; D047389:Casein Kinase I / Q000037:antagonists & inhibitors* / Q000378:metabolism; D023281:Genomics; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000201:enzymology*; D051379:Mice; D058990:Molecular Targeted Therapy; D047428:Protein Kinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D054852:Small Molecule Libraries / Q000494:pharmacology / Q000627:therapeutic use
D047428:Protein Kinase Inhibitors; D054852:Small Molecule Libraries; D047389:Casein Kinase I